Outcome of Board Meeting

25 June 2026 To To The Secretary, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd, 1st Floor, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051. Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir / Madam, Subject: Outcome of the Board meeting held on Thursday, 25 June 2026 – Noting of NCLT Order and Fixation of Record Date pursuant to the Scheme of Amalgamation Ref: Regulation 30 & 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the captioned subject, we wish to inform you that pursuant to the approval of the Scheme of Amalgamation between Quality Care India Limited (“QCIL” / “Transferor Company”) and Aster DM Healthcare Limited (“Aster” / “Transferee Company”) and their respective shareholders and creditors (“Scheme”) by the Hon’ble National Company Law Tribunal, Hyderabad Bench (“NCLT”), vide its order dated 19 June 2026, the Board of Directors of the Company at its meeting held on Thursday, 25 June 2026, inter alia: 1. Took on record the order of the Hon’ble NCLT dated 19 June 2026 approving the Scheme. 2. In terms of Clause E(dd) of Part I of the Scheme, fixed 9 July 2026 as the Record Date for the purpose of determining the entitlement of the equity shareholders of Transferor Company for allotment of fully paid-up equity shares of face value of INR 10/- each of Transferee Company, in accordance with the share exchange ratio stated under the Scheme, i.e., 977 (Nine Hundred and Seventy Seven) equity shares of the Transferee Company for every 1000 (One Thousand) equity shares held in the Transferor Company. The Meeting of the Board of Directors commenced at 12:00 PM (IST) and concluded at 03:00 PM (IST). Kindly take the above on records. Thank you, Yours faithfully, For Aster DM Healthcare Limited Hemish Purushottam Company Secretary and Compliance Officer M. No: A24331